TrademarkDir
MEERA CLINICALTRIALLINK
LIVE

Serial Number

97817528

Owner

Meera Therapeutics, Inc

Attorney

Stephen Prince

First Use Date

Dec 15, 2025

Filing Date

Mar 1, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MEERA CLINICALTRIALLINK Trademark

Serial Number: 97817528

MEERA CLINICALTRIALLINK is a trademark filed by Meera Therapeutics, Inc on March 1, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Meera Therapeutics, Inc (2 trademarks)

4201 Hartshorn Ranch Place
La Verne, CA 91750

Entity Type: 03

Trademark Details

Filing Date

March 1, 2023

Registration Date

Not Registered

First Use Anywhere

December 15, 2025

First Use in Commerce

December 15, 2025

Published for Opposition

January 9, 2024

Goods & Services

Software as a service (SAAS) services featuring software for connecting stakeholders, namely, clinical research organizations, patients, trial clinic sites, and primary care physicians, for clinical trials to improve recruitment and retention, data collection, and analytics

Medical practice management for others in the field of medical clinical trials by creating and managing appointments, documenting visit notes, oversight of enrolled patients, and patient recruitment and advertising campaigns

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 20, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 4, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 4, 2026 AITU
USE AMENDMENT FILED
Feb 17, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 17, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Aug 31, 2025 EX3G
SOU EXTENSION 3 FILED
Aug 31, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 31, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 5, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 4, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 23, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 23, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 23, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2023 CNSA
ASSIGNED TO EXAMINER
Nov 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2023 NWOS
NEW APPLICATION ENTERED
Mar 4, 2023 NWAP

Related Trademarks

More from this Owner

CLINICAL TRIAL LINK

CLINICAL TRIAL LINK